Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hidden bacteria in artery plaques may predict Post-Surgery risks

NCT ID NCT06935279

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study examined 200 adults who had surgery to remove plaque from their carotid arteries. Researchers identified bacteria living inside the plaques and tracked whether certain types were linked to later strokes, re-narrowing of the artery, or death. The goal was to learn which bacteria might be risky, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

200 people

The number who actually took part.

Started

Jan 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study is a prospective, multicentre, cohort study. This registry study is expected to be conducted mainly at the Advanced Stroke Centre of Neurosurgery, Tang Du Hospital, with another 8-10 national advanced stroke centres participating in the study, with a study population of patients aged 18-80 years undergoing CEA surgery. Patients who met all the inclusion criteria and did not fulfil any of the exclusion criteria could be considered for enrolment after indicating their informed consent to participate in this registry study and their willingness to sign an informed consent form. All patients participating in this study underwent a comprehensive standardised assessment conducted by a multidisciplinary team. The assessment included examination of neurology, neuropsychology and psychiatry, endocrine disorders, and haematological indices. Species identification of bacteria by bacterial 16SrDNA sequence sequencing will be performed and further verified by TEM, live bacterial staining

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria 1\. Patients clinically diagnosed with moderate-to-severe carotid artery stenosis 2. Age 18 ≤ age ≤ 90 3. Patients undergoing carotid endarterectomy (CEA) 4. Preoperative mRS score of 0-2 5. Preoperative NIHSS score: 0-20 6. Patient's Glasgow Coma Scale (GCS) score upon admission: 8-15 points 7. No fever or evidence of infection at admission 8. Informed consent signed by the subject or their legal representative 9. Good compliance with follow-up visits Exclusion Criteria 1. Brain tumor (presence of mass effect) 2. Patient Glasgow Coma Scale (GCS) score \< 8 3. Refractory hypertension unresponsive to medication (defined as sustained systolic blood pressure \>185 mmHg or diastolic blood pressure \>110 mmHg) 4. History of severe infection within the past three months 5. Severe or acute heart failure 6. Acute myocardial infarction or severe arrhythmia 7. Undergone major organ surgery or biopsy within the past month 8. Any active bleeding or recent bleeding (gastrointestinal, urinary tract, etc.) within the past month 9. Currently undergoing hemodialysis or peritoneal dialysis; known severe renal impairment (glomerular filtration rate \< 220 mmol/L (2.5 mg/dL)) 10. Concurrent malignant tumors, severe cardiopulmonary disease, or other conditions rendering the patient unable to tolerate surgery 11. Has participated in other interventional clinical studies that may influence the outcome assessment. 12. Severe liver function abnormalities. 13. Other circumstances deemed by the investigator to make participation in this study inappropriate or pose significant risk to the patient (e.g., inability to understand and/or comply with study procedures and/or follow-up due to psychiatric, cognitive, or emotional disorders) 14. Currently receiving immunosuppressive agents or undergoing immunotherapy 15. Severe chest or abdominal trauma requiring surgery 16. Severe Traumatic Brain Injury 17. Infectious Diseases such as Syphilis, AIDS, Hepatitis, and Tuberculosis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atherosclerosis of artery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tangdu Hospital

    Xian, Shanxi, 710000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.